Business

EBT Share Purchase

Dr. Martens plc has announced that it has recommended the Employee Benefit Trust purchase up to 10 million ordinary shares in the market, with these shares to be held unallocated for future employee share plan awards. Disclaimer*

Dr. Martens PlcJanuary 29, 20265
EBT Share Purchase

About this update from Dr. Martens Plc

Dr. Martens plc (the "Company") EBT Share Purchase The Company announces that it has recommended that FCM Trust Limited (the "Trustee"), in its capacity as trustee of the Dr Martens plc Employee Benefit Trust (the "Trust"), purchases up to 10m ordinary shares of the Company in the market, with the purchases commencing as soon as is practicable.   The shares will be held on an unallocated basis for use in satisfying both current and future awards under the Company's employee share plans from time to time.   Enquiries: Bethany Barnes, Director of Investor Relations & Corporate Communications                   +44 7825 187465 [email protected]   Paul Rolling, Head of Secretariat +44 7584 243562           [email protected]   About Dr. Martens Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot - named after the date it was produced - rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, "Docs" or "DM's" were later adopted by musicians and subcultural pioneers who took them from the street to the global stage. Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,700 people. The company continues to honour the brand's heritage through its 'Made in England' footwear, manufactured at its original Northamptonshire factory, while meeting global demand from multiple high-quality production sites across Asia. All our products are made with an unwavering commitment to craft, combined with innovative techniques. A brand built to put a bounce in the step of those who stand out from the crowd, Dr. Martens is available through Direct-to-Consumer (Retail and Ecommerce) and Wholesale channels. The brand's collections range from its Original silhouettes - The Icons such as the 1460 boot, 1461 shoe, 2976 Chelsea boot, and Adrian loafer - to modern franchises like the Zebzag, Buzz, and Lowell. The lineup also includes an extensive range of sandals, a dedicated Kids collection, and a curated selection of bags, small leather goods, and accessories. Every Dr. Martens collection reflects craftsmanship, heritage, timeless style, comfort, and versatility. Having transcended generations, the brand stays as relevant today as it was at its inception. Its signature yellow welt stitching, grooved sole edges, and scripted "With Bouncing Soles" heel loops remain iconic symbols recognised around the world. Dr. Martens plc (DOCS.L) is listed on the main market of the London Stock Exchange and is a constituent of the FTSE 250 index. For more information, visit www.drmartens.com or www.drmartensplc.com

View stock analysis, news, and events for Dr. Martens Plc

More from Dr. Martens Plc

All Dr. Martens Plc news →